Japan Agency for Medical Research and Development (AMED, 日本医療研究開発機構) is Japan’s national research and development agency dedicated to planning, funding, and managing medical R&D from basic science through clinical application and commercialization. Established to integrate and coordinate programs across multiple government ministries, it serves as a central hub linking academia, industry, and healthcare institutions.
AMED supports drug discovery, biopharmaceuticals, regenerative medicine, medical devices, infectious disease control, and genomic/precision medicine. Its programs provide competitive grants and project management, strengthen clinical research infrastructure and data platforms, and encourage translational research and scale-up, including GMP-aligned process and manufacturing technologies. The agency promotes regulatory science, standardization, and international collaboration to accelerate the development and deployment of safe, effective medical technologies. Through these initiatives, AMED helps advance innovation with relevance to the chemical and life-science industries, particularly in areas intersecting materials, bioprocessing, and pharmaceutical production.
To provide comprehensive coverage, we aggregate data and news under the name AMED, encompassing the following company names, divisions, and related entities:
日本医療研究開発機構.
This list encompasses current and former names, alternate names, and key divisions associated with AMED, ensuring you can easily find all relevant information under a single, unified profile.
